Latest Content

New analysis reveals Ingrezza's 40 mg dose significantly improves tardive dyskinesia symptoms, showcasing long-term efficacy and safety in patients.

A recent study reveals that the choice of initial antipsychotic significantly impacts long-term weight gain, highlighting the complexity of treatment outcomes.

Explore the psychological impacts of the Israel-Palestine conflict, emphasizing trauma, identity, and the potential for healing and peace through psychiatry.

Explore the critical role of social determinants in mental health, highlighting their impact on wellbeing and the need for interdisciplinary research.

Creative individuals navigate the fine line between solitude and loneliness, discovering how isolation can fuel artistic expression or lead to despair.

Maximillian Fink, MD, a pioneering psychiatrist and advocate for ECT, leaves a lasting legacy in neuropsychiatry and education.

Discover how best to approach ADHD assessments and utilize tools such as the Mentavi Diagnostic Evaluation, which can help improve patient care and reduce stigma.

Uzedy, a once-monthly extended release long-acting injectable, is now FDA approved for bipolar I disorder.

A reproductive psychiatrist discusses the implications of recent FDA announcements on medication use during pregnancy, emphasizing the importance of mental health for mothers and babies.

Explore the complexities of aripiprazole in bipolar disorder treatment, including its efficacy and proper prescribing practices.

Discover the most effective components of cognitive behavioral therapy for chronic insomnia, enhancing treatment outcomes and patient care strategies.

Cingulate's CTx-1301, a novel ADHD treatment, gains FDA review, promising rapid relief and sustained efficacy for patients.